David Silberstein
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
David S.
Silberstein currently works at Lantern Pharma, Inc., as Independent Director from 2018, Biological Mimetics, Inc., as Director from 2016, and BioMimetix Pharmaceutical, Inc., as Chief Operating Officer from 2013.
Dr. Silberstein received his doctorate degree from The Trustees of Columbia University in The City of New York.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LANTERN PHARMA, INC. -.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LANTERN PHARMA INC. | Director/Miembro de la Junta | 01/06/2018 |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Director de Operaciones | 01/01/2013 |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Miembro de la Junta | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Commercial Services |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.